TABLE 2.
Circulating arterialized metabolite concentrations during baseline and isoprenaline infusion in lean and obese subjects
Lean |
Obese |
|||||
---|---|---|---|---|---|---|
Baseline | ISO | Δ | Baseline | ISO | Δ | |
n | 13 | 10 | 10 | 10 | 7 | 7 |
TAG (μmol/l) | 701 ± 66 | 648 ± 64* | −46 ± 23 | 1,464 ± 190† | 1,667 ± 217*† | 112 ± 44‡ |
FFA (μmol/l) | 661 ± 41 | 942 ± 53* | 271 ± 46 | 638 ± 42 | 1,124 ± 82* | 469 ± 82‡ |
Glycerol (μmol/l) | 102 ± 5 | 118 ± 7* | 15 ± 5 | 106 ± 4 | 147 ± 10*† | 44 ± 9‡ |
Glycerol Ra (μmol/min) | 199 ± 12 | 311 ± 28* | 109 ± 13 | 220 ± 15 | 391 ± 30* | 172 ± 19 |
Glycerol Ra/FFM (μmol · kg−1 FFM · min−1) | 3.4 ± 0.2 | 5.5 ± 0.5* | 2.0 ± 0.5 | 3.3 ± 0.3 | 5.8 ± 0.6* | 2.5 ± 0.5 |
Glucose (mmol/l) | 5.3 ± 0.1 | 5.4 ± 0.1 | 0.14 ± 0.06 | 5.5 ± 0.2 | 5.4 ± 0.1 | −0.12 ± 0.10 |
Insulin (mU/l) | 7.2 ± 0.6 | 10.7 ± 0.9* | 3.4 ± 0.6 | 13.6 ± 1.0† | 24.0 ± 2.3*† | 10.6 ± 1.5‡ |
Lactate (mmol/l) | 0.61 ± 0.04 | 0.72 ± 0.03 | 0.09 ± 0.04 | 0.98 ± 0.11† | 0.99 ± 0.06† | 0.05 ± 0.07 |
Data are means ± SE.
P < 0.05 ISO vs. baseline.
P < 0.05 obese vs. lean.
P < 0.05 change (Δ) from baseline obese vs. lean.